Table 1.
Baseline demographics and subject characteristics
| Characteristic | OC study (N = 33) | Warfarin study (N = 15) |
Rosuvastatin (group A) n = 21 |
Simvastatin (group B) n = 21 |
|---|---|---|---|---|
| Sex | ||||
| Men, n (%) | 0 | 14 (93.3) | 20 (95.2) | 21 (100) |
| Women, n (%) | 33 (100) | 1 (6.7) | 1 (4.8) | 0 |
| Age, years | 26 | 37 | 33 (10) | 33 (11) |
| Race | ||||
| White | 27 (81.8) | 10 (66.7) | 13 (61.9) | 14 (66.7) |
| Black | 4 (12.1) | 5 (33.3) | 8 (38.1) | 5 (23.8) |
| American Indian/Alaskan | 0 | 0 | 0 | 1 (4.8) |
| Asian | 2 (6.1) | 0 | 0 | 1 (4.8) |
| Weight (kg), mean (SD) | 63.8 (9.4) | 87.2 (8.0) | 83.7 (10.8) | 80.8 (9.9) |
| Body mass index (kg/m2), mean (SD) | 23.7 (3.0) | 27.4 (3.5) | 26.2 (2.8) | 25.6 (2.7) |
OC oral contraceptive, SD standard deviation